References
- Adams, J. S., & Woods, E. R. (2016). Redesign of chronic illness care in children and adolescents: Evidence for the chronic care model. Current Opinion in Pediatrics, 28(4), 428–433. https://doi.org/https://doi.org/10.1097/MOP.0000000000000368
- American Academy of Sleep Medicine. (2014) . The international classification of sleep disorders—Third edition (ICSD-3).
- Avis, K. T., Shen, J., Weaver, P., & Schwebel, D. C. (2015). Psychosocial characteristics of children with central disorders of hypersomnolence versus matched healthy children. Journal of Clinical Sleep Medicine, 11(11), 1281–1288. https://doi.org/https://doi.org/10.5664/jcsm.5186
- Babiker, M. O. E., & Prasad, M. (2015). Narcolepsy in children: A diagnostic and management approach. Pediatric Neurology, 52(6), 557–565. https://doi.org/https://doi.org/10.1016/j.pediatrneurol.2015.02.020
- Billiard, M., Bassetti, C., Dauvilliers, Y., Dolenc-Groselj, L., Lammers, G. J., Mayer, G., Pollmächer, T., Reading, P., & Sonka, K. (2006). EFNS guidelines on management of narcolepsy. European Journal of Neurology, 13(10), 1035–1048. https://doi.org/https://doi.org/10.1111/j.1468-1331.2006.01473.x
- Black, J. E., & Hirshkowitz, M. (2005). Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep, 28(4), 464–471. https://doi.org/https://doi.org/10.1093/sleep/28.4.464
- Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/https://doi.org/10.1191/1478088706qp063oa
- Clavenna, A., & Bonati, M. (2017). Pediatric pharmacoepidemiology—Safety and effectiveness of medicines for ADHD. Expert Opinion on Drug Safety, 16(12), 1335–1345. https://doi.org/https://doi.org/10.1080/14740338.2017.1389894
- Cohen, A., Mandrekar, J., St. Louis, E. K., Silber, M. H., & Kotagal, S. (2018). Comorbidities in a community sample of narcolepsy. Sleep Medicine, 43, 14–18. https://doi.org/https://doi.org/10.1016/j.sleep.2017.11.1125
- Dorris, L., Zuberi, S. M., Scott, N., Moffat, C., & McArthur, I. (2008). Psychosocial and intellectual functioning in childhood narcolepsy. Developmental Neurorehabilitation, 11(3), 187–194. https://doi.org/https://doi.org/10.1080/17518420802011493
- Houghton, W. C., Scammell, T. E., & Thorpy, M. (2004). Pharmacotherapy for cataplexy. Sleep Medicine Reviews, 8(5), 355–366. https://doi.org/https://doi.org/10.1016/j.smrv.2004.01.004
- Ingram, D. G., Jesteadt, L., Crisp, C., & Simon, S. L. (2020). Treatment and care delivery in pediatric narcolepsy: A survey of parents, youth, and sleep physicians. Journal of Clinical Sleep Medicine. https://doi.org/https://doi.org/10.5664/jcsm.9054
- Ingram, D. G., Jesteadt, L., Crisp, C., & Simon, S. L. (2021). Perceived challenges in pediatric narcolepsy: A survey of parents, youth, and sleep physicians. Journal of Clinical Sleep Medicine, 17(1), 13–22. https://doi.org/https://doi.org/10.5664/jcsm.8774
- Inocente, C. O., Gustin, M.-P., Lavault, S., Guignard-Perret, A., Raoux, A., Christol, N., Gerard, D., Dauvilliers, Y., Reimão, R., Bat-Pitault, F., Lin, J.-S., Arnulf, I., Lecendreux, M., & Franco, P. (2014a). Depressive feelings in children with narcolepsy. Sleep Medicine, 15(3), 309–314. https://doi.org/https://doi.org/10.1016/j.sleep.2013.08.798
- Inocente, C. O., Gustin, M.-P., Lavault, S., Guignard-Perret, A., Raoux, A., Christol, N., Gerard, D., Dauvilliers, Y., Reimão, R., Bat-Pitault, F., Lin, J.-S., Arnulf, I., Lecendreux, M., & Franco, P. (2014b). Quality of life in children with narcolepsy. CNS Neuroscience & Therapeutics, 20(8), 763–771. https://doi.org/https://doi.org/10.1111/cns.12291
- Kingshott, R. N., Vennelle, M., Coleman, E. L., Engleman, H. M., Mackay, T. W., & Douglas, N. J. (2001). Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine, 163(4), 918–923. https://doi.org/https://doi.org/10.1164/ajrccm.163.4.2005036
- Kotagal, S. (2018). Treatment of narcolepsy and other organic hypersomnias in children. Paediatric Respiratory Reviews, 25, 19–24. https://doi.org/https://doi.org/10.1016/j.prrv.2017.06.012
- Miller, V. A. (2018). Involving youth with a chronic illness in decision-making: Highlighting the role of providers. Pediatrics, 142(Suppl. 3), S142–S148. https://doi.org/https://doi.org/10.1542/peds.2018-0516D
- Morrish, E., King, M. A., Smith, I. E., & Shneerson, J. M. (2004). Factors associated with a delay in the diagnosis of narcolepsy. Sleep Medicine, 5(1), 37–41. https://doi.org/https://doi.org/10.1016/j.sleep.2003.06.002
- Neikrug, A. B., Crawford, M. R., & Ong, J. C. (2017). Behavioral sleep medicine services for hypersomnia disorders: A survey study. Behavioral Sleep Medicine, 15(2), 158–171. https://doi.org/https://doi.org/10.1080/15402002.2015.1120201
- Nevsimalova, S. (2014). The diagnosis and treatment of pediatric narcolepsy. Current Neurology and Neuroscience Reports, 14(8), 469. https://doi.org/https://doi.org/10.1007/s11910-014-0469-1
- Parmar, A., Yeh, E. A., Korczak, D. J., Weiss, S. K., Lu, Z., Zweerink, A., Toulany, A., Murray, B. J., & Narang, I. (2019). Depressive symptoms, sleep patterns, and physical activity in adolescents with narcolepsy. Sleep, 42(8), zsz111. https://doi.org/https://doi.org/10.1093/sleep/zsz111
- Pérez-Carbonell, L., Lyons, E., Gnoni, V., Higgins, S., Otaiku, A. I., Leschziner, G. D., Drakatos, P., d’Ancona, G., & Kent, B. D. (2020). Adherence to wakefulness promoting medication in patients with narcolepsy. Sleep Medicine, 70, 50–54. https://doi.org/https://doi.org/10.1016/j.sleep.2020.02.013
- Pielech, M., Vowles, K., & Wicksell, R. (2017). Acceptance and commitment therapy for pediatric chronic pain: Theory and application. Children, 4(2), 10. https://doi.org/https://doi.org/10.3390/children4020010
- Rammohan, K. W. (2002). Efficacy and safety of modafinil (Provigil(R)) for the treatment of fatigue in multiple sclerosis: A two centre phase 2 study. Journal of Neurology, Neurosurgery & Psychiatry, 72(2), 179–183. https://doi.org/https://doi.org/10.1136/jnnp.72.2.179
- Rogers, A. E., Aldrich, M. S., & Lin, X. (2001). A comparison of three different sleep schedules for reducing daytime sleepiness in narcolepsy. Sleep, 24(4), 385–391. https://doi.org/https://doi.org/10.1093/sleep/24.4.385
- Taddeo, D., Egedy, M., & Frappier, J.-Y. (2008). Adherence to treatment in adolescents. Paediatrics & Child Health, 13(1), 19–24. https://doi.org/https://doi.org/10.1093/pch/13.1.19
- Thannickal, T. C., Moore, R. Y., Nienhuis, R., Ramanathan, L., Gulyani, S., Aldrich, M., Cornford, M., & Siegel, J. M. (2000). Reduced number of hypocretin neurons in human narcolepsy. Neuron, 27(3), 469–474. https://doi.org/https://doi.org/10.1016/S0896-6273(00)00058-1
- Thorpy, M. J., & Bogan, R. K. (2020). Update on the pharmacologic management of narcolepsy: Mechanisms of action and clinical implications. Sleep Medicine, 68, 97–109. https://doi.org/https://doi.org/10.1016/j.sleep.2019.09.001
- Wijnans, L., Lecomte, C., de Vries, C., Weibel, D., Sammon, C., Hviid, A., Svanström, H., Mølgaard-Nielsen, D., Heijbel, H., Dahlström, L. A., Hallgren, J., Sparen, P., Jennum, P., Mosseveld, M., Schuemie, M., van der Maas, N., Partinen, M., Romio, S., Trotta, F., … Sturkenboom, M. C. J. M. (2013). The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine, 31(8), 1246–1254. https://doi.org/https://doi.org/10.1016/j.vaccine.2012.12.015
- Wise, M. S., Auger, R. R., Brooks, S. N., & Watson, N. F. (2007). Treatment of narcolepsy and other hypersomnias of central origin. Sleep, 30(12), 1712–1727. https://doi.org/https://doi.org/10.1093/sleep/30.12.1712